跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Approved
STANDARD
ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Nov 7, 2025
Approval ID
2c4e3cc4e4f0263a
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
2c4e3cc4e4f0263a
Product Name
ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Artg Id
485480
Artg Name
ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2025-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Nov 7, 2025
Approval ID
2c4e3cc4e4f0263a
Type
Standard
Back to TGA Approvals
ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit - TGA Drug Approval Details